BerandaGXEA • FRA
add
Galapagos NV - ADR
Tutup sebelumnya
€24,60
Rentang hari
€24,60 - €24,60
Rentang tahun
€20,00 - €37,00
Kapitalisasi pasar
1,66 M EUR
Volume Rata-Rata
30,00
Rasio P/E
-
Hasil dividen
-
Dalam berita
Keuangan
Laporan Pendapatan
Pendapatan
Laba bersih
| (EUR) | Mar 2024info | Perubahan Y/Y |
|---|---|---|
Pendapatan | 62,43 jt | 6,59% |
Biaya operasional | 21,40 jt | 5,88% |
Laba bersih | 90,22 jt | 288,76% |
Margin laba bersih | 144,51 | 264,74% |
Penghasilan per saham | 0,36 | 2,86% |
EBITDA | -27,30 jt | -172,39% |
Tarif pajak efektif | -2,48% | — |
Neraca
Total aset
Total liabilitas
| (EUR) | Mar 2024info | Perubahan Y/Y |
|---|---|---|
Investasi tunai jangka pdk | 3,56 M | -10,83% |
Total aset | 4,36 M | -5,85% |
Total liabilitas | 1,47 M | -29,08% |
Total ekuitas | 2,90 M | — |
Saham yang beredar | 65,90 jt | — |
Harga terhadap reservasi | 0,56 | — |
Tingkat pengembalian aset | -1,90% | — |
Pengembalian modal | -2,90% | — |
Arus Kas
Perubahan bersih tunai
| (EUR) | Mar 2024info | Perubahan Y/Y |
|---|---|---|
Laba bersih | 90,22 jt | 288,76% |
Kas dari operasi | -122,43 jt | -29,06% |
Tunai dari investasi | 29,66 jt | 110,28% |
Tunai dari pembiayaan | -1,17 jt | -514,74% |
Perubahan bersih tunai | -93,44 jt | 75,67% |
Arus kas bebas | -124,07 jt | -261,23% |
Tentang
Galapagos NV is a Belgian pharmaceutical research company which was founded in 1999. Its headquarters are located in Mechelen and has additional locations in Leiden, Romainville, Basel, Milan, Madrid, Boston and Zagreb.
The company develops drugs against rheumatoid arthritis, Crohn's disease, ulcerative colitis, psoriasis, systemic lupus erythematosus and cystic fibrosis. Wikipedia
Didirikan
1999
Situs
Karyawan
1.123
